Laxai Pharma Ltd (LAXAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Sales | 3,227 | 2,788 | 3,102 | 3,485 | 2,857 |
| Gross Profit | 3,227 | 2,788 | 3,102 | 3,485 | 2,857 |
| Operating Income | 3,227 | 2,788 | 3,102 | 3,485 | 2,857 |
| Pre-tax Income | 3,227 | 2,788 | 3,102 | 3,485 | 2,857 |
| Net Income Continuous | 52 | 39 | 163 | 360 | -134 |
| Net Income | $52 | $39 | $163 | $360 | $-134 |
| EPS Basic Total Ops | 0.01 | 0.01 | 0.02 | 0.05 | -0.02 |
| EPS Basic Continuous Ops | 0.01 | 0.01 | 0.02 | 0.05 | -0.02 |
| EPS Diluted Total Ops | 0.01 | 0.01 | 0.02 | 0.05 | -0.02 |
| EPS Diluted Continuous Ops | 0.01 | 0.01 | 0.02 | 0.05 | -0.02 |
| EBITDA(a) | $3,227 | $2,788 | $3,102 | $3,485 | $2,857 |